日本鳗鲡腐皮病病原菌的分离及鉴定

从患腐皮病的日本鳗鲡(Anguilla japonica)体表溃烂处分离到1株病原菌(322A),对其进行了人工感染实验和生理生化分析,测定了该菌株的16S rRNA基因序列和促旋酶(gyrase)B亚单位gyrB基因序列,并分别构建系统发育树。结果显示:感染实验证实菌株322A具有致病性;生理生化分析鉴定该菌株属于气单胞菌属(Aero-monassp.);16S rRNA基因分析显示,该菌株与气单胞菌属细菌的同源性均在99%~100%,构建的系统树显示,菌株322A与嗜水气单胞菌(A.hydrophila(FJ462702))亲缘关系最近;gyrB基因分析表明,该菌株与A.hydrophila种内序列的相似性为96%~98%,种间序列的相似性为94%~95%,构建的系统树结果显示,该菌株与A.hydrophila(FJ608553、FJ608552、AF208259)聚为一个分支。综合上述实验结果,菌株322A可鉴定为嗜水气单胞菌(A.hydrophila)。     

Exploring the efficacy of vaccine techniques in juvenile sablefish,Anoplopoma fimbria

Wild sablefish, Anoplopoma fimbria, are a valuable commercial species whose populations are declining. Fortunately, sablefish are excellent species for commercial aquaculture. Sablefish raised under high‐density conditions in the marine environment require the use of efficacious vaccines to control disease. Sablefish impacted by disease in net pens may have poor flesh quality and high mortality during grow‐out. As a result, disease can cause financial hardship for sablefish aquaculture operators. The efficacy of a multivalent vaccine preparation for sablefish, administered either by intraperitoneal (i.p.) injection or by immersion, against atypical and typical Aeromonas salmonicida, the causative agents of atypical and typical furunculosis, respectively, was examined. A. salmonicida can affect sablefish at any age and size. Consequently, an efficacious vaccine that can be appropriately and optimally administered to all life stages is desirable. Sablefish vaccinated by immersion at ~1.5 or ~4.5 g with a whole‐cell multivalent vaccine were not protected against either typical or atypical A. salmonicida. Factors that may have contributed to the ineffectiveness of the immersion vaccine are discussed. By contrast, the relative per cent survival (RPS) or potency of the whole‐cell multivalent vaccine injected i.p. in juvenile sablefish at ~50 g against typical and atypical A. salmonicida was 94.3% and 81.7% respectively. The high RPS values indicated that the vaccine successfully initiated an immune response in sablefish upon a second encounter with the pathogen.     

First isolation of Vibrio tapetis and an atypical strain of Aeromonas salmonicida from skin ulcerations in common dab (Limanda limanda) in the North Sea

Skin ulcerations rank amongst the most prevalent lesions affecting wild common dab (Limanda limanda) with an increase in prevalence of up to 3.5% in the Belgian part of the North Sea. A complex aetiology of these ulcerations is suspected, and many questions remain on the exact factors contributing to these lesions. To construct the aetiological spectrum of skin ulcerations in flatfish, a one‐day monitoring campaign was undertaken in the North Sea. Fifteen fish presented with one or more ulcerations on the pigmented and/or non‐pigmented side. Pathological features revealed various stages of ulcerations with loss of epidermal and dermal tissue, inflammatory infiltrates and degeneration of the myofibers bordering the ulceration, albeit in varying degrees. Upon bacteriological examination, pure cultures of Vibrio tapetis were retrieved in high numbers from five fish and of Aeromonas salmonicida in one fish. The V. tapetis isolates showed cross‐reactivity with the sera against the representative strain of serotype O2 originating form a carpet‐shell clam (Ruditapes descussatus). Moreover, the A. salmonicida isolates displayed a previously undescribed vapA gene sequence (A‐layer type) with possible specificity towards common dab. Further research is necessary to pinpoint the exact role of these agents in the development of skin ulcerations in common dab.     

养殖鱼源嗜水气单胞菌对氟喹诺酮类药物的耐药机制

为研究体外诱导敏感嗜水气单胞菌耐药后,其敏感性变化与基因突变、外排作用的关系,实验选取对氟喹诺酮类药物敏感的养殖鱼源嗜水气单胞菌临床分离菌株为研究对象,分别在含亚抑菌浓度恩诺沙星(EN)和诺氟沙星(NF)的培养基上逐步诱导培养,以获得高耐药菌株;对诱导菌株gry A和par C基因进行扩增和测序分析;测定诱导菌对诱导药物和16种非诱导药物的最小抑菌浓度(MIC)及添加外排泵抑制剂N-甲基吡咯烷酮(NMP)后的MIC值变化;并对诱导菌交叉耐药情况进行比较分析。结果发现,诱导后菌株对EN和NF的MIC分别提高了409.6和4096倍,对非诱导氟喹诺酮类药物和其他类药物的MIC也有较大变化;药物诱导后各菌株gyr A基因和par C基因编码的氨基酸QRDRs区发生了典型的点突变:Gyr A发生Ser83→Ile变化,Par C发生Ser87→Ile/Arg变化;添加NMP后,所有诱导菌株对两种药物的MIC值均有不同程度的下降;诱导后菌株交叉耐药情况与菌株密切相关,其中3和8号诱导菌株对16种非诱导药物均无交叉耐药反应,而EN诱导菌株对氨基糖苷类和利福霉素类药物基本未产生交叉耐药反应,NF诱导菌株对除庆大霉素以外的氨基糖苷类和利福霉素类药物基本未产生交叉耐药反应,所有诱导后菌株均对四环素类和氯霉素类药物产生较严重的交叉耐药。研究表明,嗜水气单胞菌对氟喹诺酮类耐药存在靶基因位点突变及主动外排作用等多种耐药机制;且应慎重考虑在防治耐药菌株引发病害时,交叉耐药情况对选择治疗药物的影响。     

Probiotic efficiency of Bacillus sp. in Labeo rohita challenged by Aeromonas hydrophila: assessment of stress profile,haemato‐biochemical parameters and immune responses

Fish are always susceptible to a wide variety of deadly pathogens which cause a huge loss in aquaculture industries. In this investigation, we have demonstrated the in vivo probiotic efficiency of Bacillus sp. MVF1 (GenBank Acc. No. KP256503) in Labeo rohita challenged with pathogenic strain of Aeromonas hydrophila (MTCC 1739). To check the probiotic potential of the selected bacterial strain, fish were divided into four groups: control, D1, D2 and D3. A total of 100 days (70 days probiotic feeding + 71th day sampling and 28 days challenged test + 29th day sampling) of feeding trial was conducted. To establish the probiotic potential of Bacillus sp. MVF1, certain haematological parameters (haemoglobin, total erythrocyte and leucocyte count), serum biochemical parameters (total protein, albumin and globulin), immune parameters (serum lysozyme and total IgM levels) and hepatic stress profile (malondialdehyde production, superoxide dismutase and catalase activity) have been measured. Our results demonstrated that red blood cell number, white blood cell number and haemoglobin content were much higher in D2 group fish compared to other groups and control fish. Similarly, total protein contents, albumin concentration, globulin concentration, lysozyme activity and IgM production were also recorded to be highest in D2 group fish. This finding clearly indicated the probiotic potential of Bacillus sp. MVF1 in L. rohita. Furthermore, our results also demonstrated that 1 × 10⁷ CFU g^?1 feed (D2) provides better immunity compared to 1 × 10⁵ (D1) and 1 × 10⁹ (D3). Due to beneficial effects, the bacterium Bacillus sp. MVF1 might be useful in aquaculture industries to reduce the disease susceptibility.     

特异性鸡蛋抗体防治中华鳖红脖子病的初步研究

选用引起中华鳖红脖子病的嗜水气单胞菌菌株,以灭活菌株作为抗原,对母鸡进行免疫,从鸡蛋中得到抗该病原的特异性鸡蛋抗体,适用浸泡及口服免疫法,并将该特异性鸡蛋抗体应用于中华鳖红脖子病的免疫防治试验。结果表明：特异性鸡蛋抗体对中华鳖红脖子病有较强的免疫保护率,浸泡浓度大于0．6ppm时,免疫保护率可达64．3％;口服免疫法每千克饲料必须添加0．2克鸡蛋抗体时,才具有较好的免疫作用。     

氟苯尼考在鲫和草鱼体内的药代/药效动力学联合参数及其临床给药方案的研究

为研究氟苯尼考在鲫和草鱼体内的药代学、药效动力学联合参数,并制定氟苯尼考对鲫、草鱼的精确用药方案,本实验结合氟苯尼考对致病性嗜水气单胞菌CAAh01的体外药效学研究和口灌不同剂量的氟苯尼考在鲫、草鱼体内药代动力学研究,确定了氟苯尼考防治该致病菌引起的鲫和草鱼细菌性败血症的给药方案。研究结果显示,氟苯尼考对CAAh01菌株的最小抑菌浓度(MIC)为0.5μg/mL,最小杀菌浓度(MBC)为1.0μg/mL,防细菌耐药突变浓度(MPC)为6.0μg/mL,防耐药突变选择窗(MSW)为0.5~6.0μg/mL。按10、20、30 mg/kg体质量剂量对鲫、草鱼口灌氟苯尼考后,在鲫体内,血药浓度大于MPC的维持时间分别为5、8、24 h;AUC24/MIC分别为177.06、265.90、426.50;Cmax/MIC分别为15.59、21.32、31.24。在草鱼体内,血药浓度大于MPC的维持时间分别为0、0、3 h;AUC24/MIC分别为38.60、75.08、121.94;Cmax/MIC分别为4.75、10.08、19.99。研究表明,综合血药浓度维持MPC以上的时间、AUC24/MIC或Cmax/MIC指标,氟苯尼考适用于鲫细菌性疾病的防治,其防突变用药方案为剂量30 mg/kg,每日1次给药,休药期不低于20 d。对于草鱼细菌性疾病的防治,氟苯尼考不宜连续使用。     

应用间接荧光抗体技术研究水中嗜水气单胞菌的数量与鱼类出血性败血病的关系

应用间接荧光抗体技术（ＩＦＡＴ），并结合嗜水气单胞菌（Ａｈ）地区优势血清型，对鱼类出血性败血病的致病菌Ａｈ进行水中数量的测定。ＭＭ感染试验和对生产鱼塘调查的结果表明，水中Ａｈ菌量与疾病呈正相关，致病浓度又随鱼体健康低下、水中氨氮偏高、溶氧偏低等多种因子的影响而下降。本试验方法快速简便，检测对象为水体，非常适用于预测疾病的发展趋势。     

大鲵不同发育阶段及组织中内参基因稳定性评价

【目的】研究18S核糖体RNA(18SrRNA)、延伸因子1-α(EF1-α)、甘油醛-3-磷酸脱氢酶(GAPDH)、β-肌动蛋白(β-actin)和琥珀酸脱氢酶A亚基(SDHA)等5种常见内参基因在大鲵不同组织、不同发育阶段及嗜水气单胞菌感染下的稳定性,为大鲵后基因组学研究提供指导。【方法】采集3龄健康大鲵的肝脏、肠、胃、胰腺、肾脏、肌肉、皮肤、脾脏等组织,3龄、2龄、1龄、9月龄、1周龄健康大鲵的皮肤组织及嗜水气单胞菌感染大鲵后第3,5,7天的皮肤组织,提取其RNA,进行实时荧光定量PCR检测,应用3种内参基因稳定性评价分析工具(geNorm,NormFinder,BestKeeper)分析5种内参基因在大鲵不同组织、不同发育阶段以及不同病理状态下的稳定性。【结果】5种内参基因在大鲵不同组织中表达稳定性较好的是EF1-α和SDHA,而在不同发育阶段及嗜水气单胞菌感染大鲵的皮肤组织中,5种内参基因的表达稳定性不同于在不同组织中的表达,稳定性较好的是EF1-α和GAPDH。【结论】EF1-α表达最为稳定,是大鲵定量PCR首选内参基因,而SDHA、GAPDH以及β-actin表达稳定性受生理状态的影响较大,作为第二内参基因时应视试验目的而定,在不同组织中进行定量PCR比较时应选用SDHA,而在不同生理状态下则应选用GAPDH为第二或备用内参基因。     

嗜水气单胞菌ZN1攻击鳗鲡后的组织病理观察

采用1/2半致死剂量的嗜水气单胞菌ZN1对鳗鲡进行腹腔注射,在第0 d、1 d、3 d、7 d、14 d、21 d采集鳗鲡肝、脾、肾、肠,观察鳗鲡经嗜水气单胞菌活菌攻击后各脏器的组织病理变化及脏器的损伤修复情况。结果显示,嗜水气单胞菌活菌ZN1攻击后鳗鲡肝、肾、脾、肠等组织细胞均出现程度不同的病变,且持续时间长达14 d以上,同时血液中的血栓细胞急剧减少,甚至全部消失。上述结果表明嗜水气单胞菌攻击后可引发鳗鲡各脏器发生明显的病理变化,并提示在病原菌攻击引起鳗鲡血栓细胞的减少并恢复缓慢可能是嗜水气单胞菌导致宿主产生败血症状的重要病理机制。